Jefferies analyst Glen Santangelo downgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Buy to Hold with a price target of $36.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades